Related Experiment Video
Updated: Aug 6, 2026
06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
New agents for prostatic cancer activated specifically by prostatic acid phosphatase
Cancer Treatment Reports
|March 1, 1977
Summary
New cytotoxic compounds (spindle poisons) targeting prostatic carcinoma were designed using prostatic acid phosphatase (PAP) substrates. Modifications to colchicine and thiocolchicine structures yielded novel compounds with preliminary toxicity and specificity data reported.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Oncology
Background:
- Prostatic carcinoma treatment requires novel cytotoxic agents.
- Spindle poisons are a class of compounds with potential anticancer activity.
- Prostatic acid phosphatase (PAP) is a target for drug design in prostate cancer.
Purpose of the Study:
- To design and synthesize potential cytotoxic compounds for prostatic carcinoma treatment.
- To utilize the structural requirements of prostatic acid phosphatase (PAP) substrates in drug design.
- To explore modifications of colchicine and thiocolchicine structures.
Main Methods:
- Chemical synthesis of modified colchicine and thiocolchicine derivatives.
- Preparation of colchiceinamides, ethanolamines, ethanolaminephosphates, and thiocolchicine O-phosphates.
- Evaluation of compound specificity toward PAP.
- Assessment of compound toxicity in mice.
- Preliminary in vivo examination of a selected compound in stumptail monkeys.
Main Results:
- Several new series of compounds, including colchiceinamides and thiocolchicine derivatives, were synthesized.
- One thiocolchicine O-phosphate was examined for PAP specificity.
- Toxicity data for the synthesized compounds in mice were reported.
- Preliminary results from stumptail monkey studies of colchiceinamide-(L)-ephedrinephosphate are available.
Conclusions:
- Novel cytotoxic compounds based on colchicine and thiocolchicine scaffolds were successfully designed and synthesized.
- The synthesized compounds show potential for prostatic carcinoma treatment.
- Further investigation into the specificity, toxicity, and efficacy of these compounds is warranted.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...